Hamps Bio Ltd

544312

Summary

Fair Value Assessment
Undervalued (5% Discount)
Fair ValueQ48.87UncertaintyVery High
Close Price46.05Mar 24, 2025
Market Closed
45.00
Price Down by 1.05 | 2.28 %
Previous Close
46.05
Day Range
45.00 – 46.90
Year Range
45.00 – 107.20
Bid / Ask
Market Cap
196.0 Mil
Volume / Average
6.0 k / 28.5 k
Beta
Shares Outstanding
4.36 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
Contact
Palanpur Canal Road Shop No 120-121-122, 01st Floor Royal Platinum, Surat, GJ 395 009
T +91 7046085555
www.hampsbio.com opens in a new tab
Sector
Healthcare
Industry
Pharmaceutical Retailers
Most Recent Earnings
Oct 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
78

Key Metrics

Income Statement (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
59.38 59.38 49.36 53.41
Revenue Growth %
20.31% 20.31% -7.58%
Gross Profit
35.74 35.74 26.09 27.74
Gross Profit Margin %
60.19% 60.19% 52.85% 51.93%
Operating Income
7.74 7.74 5.28 2.90
Operating Margin %
13.03% 13.03% 10.69% 5.44%
EBIT
7.86 7.86 5.25 2.89
EBIT Margin %
13.24% 13.24% 10.63% 5.40%
EBITDA
11.90 11.90 8.64 6.14
EBITDA Margin %
20.04% 20.04% 17.50% 11.49%
Net Income
5.01 5.01 3.59 1.22
Net Profit Margin %
8.43% 8.43% 7.27% 2.28%
Basic EPS
1.15 1.15 0.82 0.28
Diluted EPS
1.15 1.15 0.82 0.28
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2020
Total Assets
51.48 51.48 39.59 36.43
Total Liabilities
17.74 17.74 25.96 26.37
Total Debt
10.45 10.45 17.38 20.43
Total Equity
33.74 33.74 13.63 10.06
Cash And Cash Equivalents
0.58 0.58 0.49 0.51
Working Capital
10.32 10.32 -8.42 -4.71
Shares Outstanding (Mil)
4.36 4.36
Book Value Per Share
Total Debt To Equity
0.31 0.31 1.27 2.03
Cash Flow Statement (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-2.92 -2.92 12.30 3.33
Cash From Investing Activities
-3.67 -3.67 -7.49 5.08
Cash From Financing Activities
6.68 6.68 -4.83 -9.44
Capital Expenditures
3.62 3.62 8.29 2.91
Free Cash Flow
4.75 4.75 -1.38 1.36
Change in Cash
0.10 0.10 -0.02 -1.03

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top